Valuation: Solara Active Pharma Sciences Limited

Market Cap 20.5B 214M 183M 171M 157M 295M 301M 2.03B 791M 10.27B 804M 787M 34.01B P/E 2024
-2.35x
P/E 2025 3,792x
Enterprise Value 28.42B 297M 254M 237M 218M 409M 417M 2.81B 1.1B 14.24B 1.12B 1.09B 47.15B EV / Sales 2024
1.76x
EV / Sales 2025 2.54x
Free-Float
47.76%
Yield 2024 *
-
Yield 2025 -
1 day-3.61%
1 week+20.42%
Current month+20.12%
1 month+10.40%
3 months+9.33%
6 months+30.62%
Current year+9.20%
1 week 501.95
Extreme 501.95
654.4
1 month 471.55
Extreme 471.55
654.4
Current year 422
Extreme 422
654.4
1 year 422
Extreme 422
712
3 years 286
Extreme 286
882.8
5 years 286
Extreme 286
1,749
10 years 134.5
Extreme 134.5
1,859.95
Manager TitleAgeSince
Chief Executive Officer - 2025-02-20
Director of Finance/CFO - 2025-02-20
Compliance Officer - 2025-05-14
Director TitleAgeSince
Chairman 73 2018-04-10
Director/Board Member 58 2018-04-10
Director/Board Member 75 2023-11-13
Date Insider Type Main position Quantity % Market Cap.
3/14/25 Buy

Director

1,000 0.0021%
3/6/25
Pronomz Ventures LLP
BuyCompany 13,600 0.0283%
3/4/25
Pronomz Ventures LLP
BuyCompany 216,361 0.4503%
Change 5-day change 1-year change 3-year change Capi.($)
-3.61%+20.42%-2.16%+75.11% 322M
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.20%+3.38%+39.85%+44.36% 371B
-1.00%+2.21%+21.66%+39.04% 301B
-0.47%+5.00%-0.13%+12.73% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-0.08%+0.53%-16.81%-53.02% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -0.79%+5.05%+26.06%+53.00% 376.14B
Weighted average by Cap. -0.16%+3.26%+42.72%+70.03%

Financials

2024 2025
Net sales 12.89B 135M 115M 108M 98.74M 186M 189M 1.28B 498M 6.46B 506M 495M 21.39B 12.84B 134M 115M 107M 98.35M 185M 188M 1.27B 496M 6.43B 504M 493M 21.3B
Net income -5.67B -59.3M -50.77M -47.37M -43.47M -81.68M -83.28M -562M -219M -2.84B -223M -218M -9.41B 5.4M 56.44K 48.32K 45.08K 41.37K 77.73K 79.26K 535K 208K 2.71M 212K 207K 8.96M
Net Debt 9.3B 97.2M 83.22M 77.65M 71.25M 134M 137M 921M 359M 4.66B 365M 357M 15.43B 7.92B 82.79M 70.88M 66.13M 60.68M 114M 116M 785M 306M 3.97B 311M 304M 13.14B
Logo Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.
Employees
1,775
Date Price Change Volume
26-08-21 616.90 -3.61% 732,550
26-08-20 ₹640.00 +16.35% 6,915,687
26-08-19 ₹550.05 +0.18% 121,098
26-08-18 ₹549.05 +7.85% 673,349
26-08-17 ₹509.10 -0.62% 75,893

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SOLARA Stock